Previous studies on genetic variation of SOD2 have mainly focused on obesity (Lewandowski et al., 2020), T2D (Flekac et al., 2008), NASH (Huang et al., 2021) and even fibrosis (Al-Serri et al., 2012). Here, SOD2 is linked to metabolic dysfunction-associated steatohepatitis.